» Articles » PMID: 32764794

Plasma Biomarkers of the Amyloid Pathway Are Associated with Geographic Atrophy Secondary to Age-related Macular Degeneration

Overview
Journal PLoS One
Date 2020 Aug 9
PMID 32764794
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration (AMD), in which local inflammation and hyperactivity of the complement pathway have been implicated in its pathophysiology. This study explores whether any surrogate biomarkers are specifically associated with GA. Plasma from subjects with GA, intermediate dry AMD and non-AMD control were evaluated in 2 cohorts. Cohort 1 was assayed in a 320-analyte Luminex library. Statistical analysis was performed using non-parametric and parametric methods (Kruskal-Wallis, principal component analysis, partial least squares and multivariate analysis of variance (MANOVA) and univariate ANCOVAs). Bioinformatic analysis was conducted and identified connections to the amyloid pathway. Statistically significant biomarkers identified in Cohort 1 were then re-evaluated in Cohort 2 using individual ELISA and multiplexing. Of 320 analytes in Cohort 1, 273 were rendered measurable, of which 56 were identified as changing. Among these markers, 40 were identified in univariate ANCOVAs. Serum amyloid precursor protein (sAPP) was analyzed by a separate ELISA and included in further analyses. The 40 biomarkers, sAPP and amyloid-β (Aβ) (1-42) (included for comparison) were evaluated in Cohort 2. This resulted in 11 statistically significant biomarkers, including sAPP and Aβ(1-40), but not Aβ(1-42). Other biomarkers identified included serum proteases- tissue plasminogen activator, tumor-associated trypsinogen inhibitor, matrix metalloproteinases 7 and 9, and non-proteases- insulin-like growth factor binding protein 6, AXL receptor tyrosine kinase, omentin, pentraxin-3 and osteopontin. Findings suggest that there is a preferential processing of APP to Aβ(1-40) over Aβ(1-42), and a potential role for the carboxylase activity of the γ-secretase protein, which preferentially splices sAPPβ to Aβ(1-40). Other markers are associated with the breakdown and remodeling of the extracellular matrix, and loss of homeostasis, possibly within the photoreceptor-retinal pigment epithelium-choriocapillaris complex. These data suggest novel disease pathways associated with GA pathogenesis and could provide potential novel targets for treatment of GA.

Citing Articles

Sigma-2 receptor modulator CT1812 alters key pathways and rescues retinal pigment epithelium (RPE) functional deficits associated with dry age-related macular degeneration (AMD).

Lizama B, Keeling E, Cho E, Malagise E, Knezovich N, Waybright L Sci Rep. 2025; 15(1):4256.

PMID: 39929889 PMC: 11810999. DOI: 10.1038/s41598-025-87921-9.


Hallmarks of aging in age-related macular degeneration and age-related neurological disorders: novel insights into common mechanisms and clinical relevance.

Vujosevic S, Limoli C, Kozak I Eye (Lond). 2024; .

PMID: 39289517 DOI: 10.1038/s41433-024-03341-5.


Disturbed Matrix Metalloproteinases Activity in Age-Related Macular Degeneration.

Martins B, Fernandes R Adv Exp Med Biol. 2023; 1415:21-26.

PMID: 37440009 DOI: 10.1007/978-3-031-27681-1_4.


An Exploratory Study Provides Insights into MMP9 and Aβ Levels in the Vitreous and Blood across Different Ages and in a Subset of AMD Patients.

Lynn S, Soubigou F, Dewing J, Smith A, Ballingall J, Sass T Int J Mol Sci. 2022; 23(23).

PMID: 36498929 PMC: 9736887. DOI: 10.3390/ijms232314603.


A1-40 Oligomers Trigger Neutrophil Extracellular Trap Formation through TLR4- and NADPH Oxidase-Dependent Pathways in Age-Related Macular Degeneration.

Chen J, Zhao L, Ding X, Wen Y, Wang L, Shu Q Oxid Med Cell Longev. 2022; 2022:6489923.

PMID: 35761872 PMC: 9233592. DOI: 10.1155/2022/6489923.


References
1.
Krogh Nielsen M, Subhi Y, Molbech C, Nilsson L, Nissen M, Sorensen T . Imbalances in tissue inhibitors of metalloproteinases differentiate choroidal neovascularization from geographic atrophy. Acta Ophthalmol. 2018; 97(1):84-90. DOI: 10.1111/aos.13894. View

2.
Smailhodzic D, Klaver C, Klevering B, Boon C, Groenewoud J, Kirchhof B . Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Ophthalmology. 2011; 119(2):339-46. DOI: 10.1016/j.ophtha.2011.07.056. View

3.
Almonte A, Sweatt J . Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior. Brain Res. 2011; 1407:107-22. PMC: 3148282. DOI: 10.1016/j.brainres.2011.06.042. View

4.
Holz F, Sadda S, Busbee B, Chew E, Mitchell P, Tufail A . Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials. JAMA Ophthalmol. 2018; 136(6):666-677. PMC: 6145777. DOI: 10.1001/jamaophthalmol.2018.1544. View

5.
Juel H, Faber C, Munthe-Fog L, Bastrup-Birk S, Reese-Petersen A, Falk M . Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration. PLoS One. 2015; 10(7):e0132800. PMC: 4503310. DOI: 10.1371/journal.pone.0132800. View